Emad A Rakha Selected Research

Phenobarbital (Luminal)

1/2022	Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer.
12/2021	Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study.
10/2021	Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.
9/2021	SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer.
8/2021	The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer.
9/2020	The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
6/2020	Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer.
5/2020	PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer.
1/2018	The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours.
1/2018	Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emad A Rakha Research Topics

Disease

182	Breast Neoplasms (Breast Cancer) 06/2022 - 07/2004
100	Neoplasms (Cancer) 06/2022 - 01/2005
26	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2022 - 08/2012
21	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2008
13	Carcinoma (Carcinomatosis) 01/2021 - 05/2009
11	Carcinogenesis 01/2022 - 02/2013
9	Breast Ductal Carcinoma 05/2022 - 12/2018
8	Triple Negative Breast Neoplasms 10/2021 - 01/2007
8	Ovarian Neoplasms (Ovarian Cancer) 04/2021 - 01/2019
8	Ductal Carcinoma 01/2020 - 01/2008
7	Ovarian Epithelial Carcinoma 04/2021 - 01/2019
7	Lobular Carcinoma 11/2020 - 05/2005
6	Necrosis 01/2020 - 01/2018
5	Disease Progression 08/2021 - 08/2012
5	Papillary Carcinoma 01/2020 - 08/2012
4	Lymphatic Metastasis 12/2021 - 04/2017
4	Genomic Instability 01/2021 - 01/2017
3	Intraductal Papilloma 01/2020 - 01/2016
3	Acinar Cell Carcinoma 12/2019 - 10/2015
3	Residual Neoplasm 11/2019 - 09/2015
2	Hypoxia (Hypoxemia) 01/2022 - 10/2019
2	Margins of Excision 11/2019 - 01/2018
2	Ataxia (Dyssynergia) 10/2019 - 03/2013
2	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2019 - 06/2018
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2017 - 04/2016
2	Breast Carcinoma In Situ 10/2010 - 03/2009
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	COVID-19 11/2021
1	Infections 11/2021
1	Acute Lung Injury 11/2021

Drug/Important Bio-Agent (IBA)

82	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2007
45	Biological ProductsIBA 01/2022 - 01/2005
34	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2007
31	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
29	Phenobarbital (Luminal)FDA Link 01/2022 - 07/2008
26	Estrogen ReceptorsIBA 01/2022 - 01/2005
17	Hormones (Hormone)IBA 05/2022 - 10/2007
14	human ERBB2 proteinIBA 01/2022 - 07/2011
13	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2007
12	Cadherins (E-Cadherin)IBA 01/2019 - 05/2005
11	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2005
8	PlatinumIBA 04/2021 - 01/2019
7	Eosine Yellowish-(YS) (Eosin)IBA 06/2022 - 08/2010
6	Indicators and Reagents (Reagents)IBA 12/2021 - 08/2008
6	Glutamine (L-Glutamine)FDA Link 01/2021 - 01/2018
5	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2022 - 01/2018
5	Phosphotransferases (Kinase)IBA 01/2022 - 12/2014
5	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 11/2021 - 03/2013
5	Tamoxifen FDA LinkGeneric 09/2021 - 01/2010
5	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 01/2015
5	Androgen Receptors (Androgen Receptor)IBA 07/2019 - 01/2007
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
4	Trastuzumab (Herceptin)FDA Link 01/2022 - 04/2014
4	Pharmaceutical PreparationsIBA 01/2021 - 10/2013
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 01/2015
4	AntibodiesIBA 01/2020 - 04/2013
4	olaparibIBA 01/2020 - 12/2018
3	Hematoxylin (Haematoxylon)IBA 06/2022 - 01/2018
3	Large Neutral Amino Acid-Transporter 1IBA 01/2022 - 01/2018
3	Poly (ADP-Ribose) Polymerase-1IBA 01/2020 - 01/2015
3	AnthracyclinesIBA 08/2019 - 01/2017
3	ParaffinIBA 01/2016 - 07/2004
3	erucylphosphocholineIBA 01/2016 - 08/2012
3	Steroid Receptors (Steroid Receptor)IBA 01/2010 - 08/2008
3	ErbB Receptors (EGF Receptor)IBA 04/2009 - 01/2005
2	UbiquitinIBA 04/2022 - 01/2018
2	Lapatinib (GW572016)FDA Link 01/2022 - 01/2021
2	DNA HelicasesIBA 11/2021 - 01/2021
2	GlutaminaseIBA 08/2021 - 03/2020
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 08/2012
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 02/2017
2	Ligases (Synthetase)IBA 01/2021 - 01/2018
2	Estrogen Receptor alphaIBA 11/2020 - 03/2009
2	Monoclonal AntibodiesIBA 01/2020 - 02/2013
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2019 - 02/2017
2	TensinsIBA 10/2019 - 02/2017
2	CollagenIBA 10/2019 - 10/2019
2	GTP-Binding Proteins (G-Protein)IBA 05/2018 - 04/2015
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2018 - 04/2015
2	RecQ HelicasesIBA 01/2017 - 03/2016
2	CateninsIBA 04/2013 - 10/2010
2	Histones (Histone)IBA 08/2010 - 05/2009
1	Aurora Kinase AIBA 05/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2022
1	Ubiquitin-Conjugating EnzymesIBA 04/2022
1	Cyclin B2IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	DNA Polymerase beta (DNA Polymerase IV)IBA 11/2021
1	Protein Isoforms (Isoforms)IBA 08/2021
1	Flap EndonucleasesIBA 07/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 02/2021
1	RANK LigandIBA 01/2021

Therapy/Procedure

66	Therapeutics 06/2022 - 10/2005
9	Drug Therapy (Chemotherapy) 02/2021 - 04/2009
7	Radiotherapy 01/2020 - 12/2014
6	Segmental Mastectomy (Lumpectomy) 11/2021 - 04/2017
3	Neoadjuvant Therapy 01/2021 - 09/2015
2	Ligation 05/2014 - 04/2014
1	Operative Surgical Procedures 05/2021